Open access
Oct 2026
A Blood-Based Synaptic Biomarker in Neuronally-Enriched Extracellular Vesicles Predicts Disability Progression in Progressive Multiple Sclerosis
NEV synaptopodin is identified as a prognostic and longitudinal, blood biomarker of synaptic integrity in PMS, particularly SPMS, complementing NfL.
L. Jank, M. K. S. Kumar, D. Joshi et al.
· medRxiv · 0 citations